CALLIDITAS THERAPEUTICS financial statements, including revenue, expenses, profit, and loss
The total revenue of LC8 for the last quarter is 40.38 M EUR, and it's 58.88% higher compared to the previous quarter. The net income of Q4 23 is -1.64 M EUR.